Group One Trading
CGON icon

Group One Trading’s CG Oncology CGON Stock Holding History

Group One Trading’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$257K Hold
3,800
– – ﹤0.01% 3911
2025
Q4 		$158K Buy
3,800
+1,700
+81% +$70.3K ﹤0.01% 4599
2025
Q3 		$84.6K Sell
2,100
-13,500
-87% -$392K ﹤0.01% 5492
2025
Q2 		$406K Buy
15,600
+14,100
+940% +$340K ﹤0.01% 3633
2025
Q1 		$36.7K Buy
+1,500
New +$42.2K ﹤0.01% 5401

Other funds holding CGON

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Group One Trading's CGON Position: Q1 2026 in Review

Group One Trading opened a new position in CG Oncology (CGON) in Q1 2026: 1,435 shares worth $97.1K. The stake represents ﹤0.01% of the portfolio and ranks #4758 among its holdings. This is a return to the name: Group One Trading previously reported a position in CGON as recently as Q2 2025.

Group One Trading first reported a position in CGON in Q2 2025 and has held it in 2 quarters since. The position peaked at $104K in Q2 2025. 233 funds tracked by Wall St. Rank hold CGON as of Q1 2026.

  • Group One Trading held 1,435 shares of CG Oncology worth $97.1K as of Q1 2026.
  • CG Oncology was a new Group One Trading position in Q1 2026.
  • CG Oncology made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #4758 holding.
  • Group One Trading first reported a position in CG Oncology in Q2 2025 and has held it in 2 quarters since.
  • Group One Trading's CG Oncology position peaked at $104K in Q2 2025.
  • 233 funds tracked by Wall St. Rank held CG Oncology as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.